Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Anti-muscarinic adjunct therapy accelerates functional human oligodendrocyte repair.
Indoleamine 2,3 Dioxygenase (IDO) Expression and Activity in Relapsing- Remitting Multiple Sclerosis.
Premature immune senescence in children with MS: Too young to go steady.
Diagnostic ability of a new method for measuring haemoglobin levels in the optic nerve head in multiple sclerosis patients.
New mutation in periaxin gene causing charcot marie tooth disease in a puerto rican young male.
Gray Matters in Multiple Sclerosis: Cognitive Impairment and Structural MRI.
The Importance of Nitric Oxide and Arginase in the Pathogenesis of Acute Neuroinflammation: Are Those Contra Players with the Same Direction?
Efficacy of vaccination against influenza in patients with multiple sclerosis: The role of concomitant therapies.
A subtraction pipeline for automatic detection of new appearing multiple sclerosis lesions in longitudinal studies.
Does fatigue complaint reflect memory impairment in multiple sclerosis?
Cerebrospinal fluid ferritin-Unspecific and unsuitable for disease monitoring.
One year follow-up of a pragmatic multi-centre randomised controlled trial of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.
Outcome measures in multiple sclerosis.
Demographic and clinical profile of myelopathy patients.
Correction: A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
Drawing on related knowledge to advance multiple sclerosis falls-prevention research.
Intradetrusorial Botulinum Toxin in Patients with Multiple Sclerosis: A Neurophysiological Study.
Higher intake of omega-3 polyunsaturated fatty acids is associated with a decreased risk of a first clinical diagnosis of central nervous system demyelination: Results from the Ausimmune Study.
Perspectives on cytokine-directed therapies in multiple sclerosis.
Comparative Effectiveness Using A Matching-Adjusted Indirect Comparison Between Delayed-Release Dimethyl Fumarate and Fingolimod for The Treatment of Relapsing-Remitting Multiple Sclerosis.
Neurodegenerative Diseases: from available treatments to prospective herbal therapy.
Neurogenic lower urinary tract dysfunction in the early disease phase of paediatric multiple sclerosis.
Modeling leukocyte trafficking at the human blood-nerve barrier in vitro and in vivo geared towards targeted molecular therapies for peripheral neuroinflammation.
Targeting two-pore domain potassium channels - A promising strategy for treating T cell mediated autoimmunity.

Pages